0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Contribution |  May 15, 2013
Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention
Pamela N. Peterson, MD, MSPH; Paul D. Varosy, MD; Paul A. Heidenreich, MD; et al.
JAMA. 2013;309(19):2025-2034. doi:10.1001/jama.2013.4982.
INCLUDES: , Supplemental Content
Editorial |  May 08, 2013
Reducing Shocks and Improving Outcomes With Implantable Defibrillators
Merritt H. Raitt, MD
JAMA. 2013;309(18):1937-1938. doi:10.1001/jama.2013.5561.
Original Contribution |  May 08, 2013
Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery:  The ADVANCE III Randomized Clinical Trial
Maurizio Gasparini, MD; Alessandro Proclemer, MD; Catherine Klersy, MD, MSc; et al.
JAMA. 2013;309(18):1903-1911. doi:10.1001/jama.2013.4598.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  April 24, 2013
New Guidance for ICD Implantation Offers Decision Aids for Physicians and Patients
Mike Mitka, MSJ
JAMA. 2013;309(16):1671-1672. doi:10.1001/jama.2013.3541.
Viewpoint |  February 27, 2013
The Value of Low-Value Lists
Adam G. Elshaug, PhD, MPH; J. Michael McWilliams, MD, PhD; Bruce E. Landon, MD, MBA
JAMA. 2013;309(8):775-776. doi:10.1001/jama.2013.828.
INCLUDES: , Supplemental Content
Original Contribution |  January 02, 2013
Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials
Sana M. Al-Khatib, MD, MHS; Anne Hellkamp, MS; Gust H. Bardy, MD; et al.
JAMA. 2013;309(1):55-62. doi:10.1001/jama.2012.157182.
INCLUDES: , Supplemental Content
Viewpoint |  March 21, 2012
Evaluating Sex Differences in Medical Device Clinical Trials:  Time for Action
Sanket S. Dhruva, MD; Rita F. Redberg, MD, MSc
JAMA. 2012;307(11):1145-1146. doi:10.1001/jama.2012.254.
Capitol Health Call |  March 14, 2012
Seeking Price Transparency
Mike Mitka
JAMA. 2012;307(10):1015. doi:10.1001/jama.2012.256.
Medical News and Perspectives |  August 24, 2011
Longer Pauses Between CPR Compressions and Defibrillation May Decrease Survival
Mike Mitka
JAMA. 2011;306(8):813-814. doi:10.1001/jama.2011.1195.
Medical News & Perspectives |  March 09, 2011
First MRI-Safe Pacemaker Receives Conditional Approval From FDA
Mike Mitka
JAMA. 2011;305(10):985-986. doi:10.1001/jama.2011.273.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  February 18, 2013
Patient Perceptions, Physician Communication, and the Implantable Cardioverter-Defibrillator
Paul J. Hauptman, MD; John T. Chibnall, PhD; Camelia Guild, MPH; et al.
JAMA Internal Medicine
Invited Commentary  |  February 18, 2013
Less Patient-Centered Care: An Unintended Consequence of Guidelines?:   Comment on “Patient Perceptions, Physician Communication, and the Implantable Cardioverter-Defibrillator”
Grace A. Lin, MD, MAS; Daniel D. Matlock, MD, MPH
JAMA Internal Medicine
Review Article  |  April 1, 2013
Implantable Cardioverter-Defibrillator Shocks:  Epidemiology, Outcomes, and Therapeutic Approaches
Ryan T. Borne, MD; Paul D. Varosy, MD; Frederick A. Masoudi, MD, MSPH
JAMA Internal Medicine
Challenges in Clinical Electrocardiography  |  March 11, 2013
Finding Needles in a Haystack—Discussion
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems